← Evidence map

ArticleLeukemia2020

Is it beneficial to use hydroxychloroquine and imatinib combination in order to achieve deeper molecular responses in patients with chronic myeloid leukemia?

Ahmet Emre EşkazanPubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2020
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32203136